We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

The global Central Lab Services/Clinical Trial Lab Services Market, valued at US$5.64 billion in 2024, is forecasted to grow at a robust CAGR ...

SiMa.ai, the software-centric, embedded edge machine learning system-on-chip (MLSoC) company, has been named to Fast Company's prestigious list of the world's Most Innovative Companies for 2025.

The stock's rise snapped a four-day losing streak.

The global Clinical Trial Services Market, valued at US$60.76 billion in 2024, is forecasted to grow at a robust CAGR of 8.9% ...

Shares of Thermo Fisher Scientific Inc. TMO slid 2.39% to $514.20 Tuesday, on what proved to be an all-around rough trading ...

Explore Thermo Fisher's latest developments in transmission electron microscopy (TEM) technology, specifically focusing on ...

According to a comprehensive report from The Insight Partners, "Molecular Spectroscopy Market share and Forecasts 2022 - 2030, Global and Regional Share ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

The global PFAS Testing Market, valued at US$379.2 million in 2023, is forecasted to grow at a robust CAGR of 14.5%, reaching ...

Citi lowered the firm’s price target on Thermo Fisher (TMO) to $570 from $650 and keeps a Neutral rating on the shares. The firm updated models in the life science tools and diagnostics group post the ...

DelveInsight's In Situ Hybridization Market Insights report provides the current and forecast market analysis, individual ...